decisionhealth Newsletters, Coder Pink Sheets - 2009 Issue 8 (August)
MultiSpecialty RoundUp: Urology
Subscribe or sign in to view the full article.
Article Overview
This article discusses two common urology coding and billing topics: payer handling of prostate cancer drug reimbursement when a least costly alternative policy applies, and coding considerations for topical chemotherapy used in genital wart care. It is aimed at urology coders, billers, and practices that need to align claims with Medicare and payer policy updates while avoiding avoidable reimbursement problems.
Why This Topic Matters
The article helps urology practices understand how payer policies may affect payment for drug administration and related patient financial responsibility, and it highlights the need to verify local coverage and payer-specific rules before billing.
Article Sections
-
Prostate cancer drugs: some patients may pay the difference
Discusses payer policies affecting reimbursement for prostate cancer drug therapy in a urology setting, including the role of local coverage guidance and patient cost responsibility considerations.
-
Another urology coding tip: topical chemotherapy for genital warts
Covers coding guidance for topical chemotherapy used in genital wart treatment and notes that payer policies may vary.
What You Will Learn
- How payer coverage policies can affect reimbursement for prostate cancer drug therapy in urology
- Why local coverage guidance and patient acknowledgement documents may matter in higher-cost drug scenarios
- How topical chemotherapy treatment for genital warts is discussed in relation to office visit coding
- Why payer-specific policy review remains important in urology billing workflows
Who Should Read This
- Urology coders
- Medical billers
- Urology practice managers
- Revenue cycle staff
- Physician practices
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com